ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A KRAS-Associated Signature for Prognostic, Immune and Chemical Anti-Cancer Drug-Response Prediction in Colon Cancer

Luo, Kangjia; Song, Yanni; Guan, Zilong; Ou, Suwen; Ye, Jinhua; Ran, Songlin; Wang, Hufei; Tao, Yangbao; Gong, Zijian; Ma, Tianyi; Jin, Yinghu; Huang, Rui*; Gao, Feng*; Yu, Shan*哈尔滨医科大学
Frontiers in Pharmacology2022-6-14DOI: 10.3389/fphar.2022.899725
1被引5阅读
引用收藏
分享

摘要

Background: KRAS mutation, one of the most important biological processes in colorectal cancer, leads to poor prognosis in patients. Although studies on KRAS have concentrated for a long time, there are currently no ideal drugs against KRAS mutations.Methods: Different expression analysis and weighted gene coexpression network analysis was conducted to select candidate genes. Log-rank tests and Cox regression picked out the prognostic genes to build a KRAS-related gene prognostic score (KRGPS). A nomogram based on KRGPS was built to predict survival of clinical patients. Comprehensive analysis showed the prognosis, immune microenvironment and response to immune therapy and chemotherapy in KRGPS subgroups.Results: We collected a KRGPS from the set of two genes GJB6 and NTNG1, with low-KRGSP patients having better progression-free survival (PFS). Low KRGPS is correlated with high infiltration of activated NK cells, plasma cells and activated memory CD4 T cells and that these cells benefit more from immune checkpoint inhibitor therapy. However, high KRGPS is associated with high infiltration of activated mast cells, pathways of immune dysregulation and a high ratio of TP53 and KRAS mutations. KRGPS subgroups are also sensitive to chemotherapy differently. A nomogram, established based on the KRGPS and pathological stage, predict 3- and 5-years PFS well.Conclusions: The KRAS-associated score acts as a promising signature to distinguish prognosis, molecular and immune characteristics, and benefits from immune and chemical therapy. These KRAS-associated genes could be promising targets for drug design.

学科与关键词

关键词
KRAS mutationcolorectal cancerprognostic signatureimmune microenvironmentimmunechemotherapy
相关
加载中…
  • Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer
    Li, Yan; Li, Yiyi; Xia, Zijin; Zhang, Dun; Chen, Xiaomei; Wang, Xinyu; Liao, Jing; Yi, Wei*; Chen, Jun*Aging-US, 2021, 13(23): 25518-25549.被引 2
  • KRAS modulates immune infiltration levels and survival outcomes in patients with lung adenocarcinoma
    Li, Na; Tian, Yue; Liu, Xin; Pan, Ciming; Xue, Jian*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(52): e36597.
  • Identification and Validation of a Novel Prognostic Gene Model for Colorectal Cancer
    Meng, Yan; Zhou, Rulin; Lin, Zhizhao; Peng, Qun; Ding, Jian; Huang, Mei; Li, Yiwen; Guo, Xuxue; Zhuang, Kangmin*Computational and Mathematical Methods in Medicine, 2022, 2022: 9774219.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-06-14
卷期
第 13 卷
页码
899725
DOI
10.3389/fphar.2022.899725
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Ministry of Education Chunhui Project Cooperative Research Project [HLJ2019010]; Heilongjiang Natural Science Foundation of China [LH 2020H120]; Haiyan Research Fund of Harbin Medical University Cancer Hospital [JJZD 2020-04]; National Natural Science Foundation of China [81872034]; Chen Xiao-ping Foundation For The Development Of Science and Technology of Hubei Province [CXPJJH12000002-2020025]; Wu Jieping Medical Foundation [320.6750.18492]

作者

  • L

    Luo, Kangjia (第一作者)

    2 · harbin med univ

  • S

    Song, Yanni

    harbin med univ

查看全部 14 位作者收起作者
  • G

    Guan, Zilong

    2 · harbin med univ

  • O

    Ou, Suwen

    2 · harbin med univ

  • Y

    Ye, Jinhua

    2 · harbin med univ

  • R

    Ran, Songlin

    2 · harbin med univ

  • W

    Wang, Hufei

    2 · harbin med univ

  • T

    Tao, Yangbao

    2 · harbin med univ

  • G

    Gong, Zijian

    2 · harbin med univ

  • M

    Ma, Tianyi

    2 · harbin med univ

  • J

    Jin, Yinghu

    2 · harbin med univ

  • H

    Huang, Rui (通讯)

    2 · harbin med univ

  • G

    Gao, Feng (通讯)

    ningbo univ

  • Y

    Yu, Shan (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417